Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours ยท Estimated delivery Aug 25 - Aug 30
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
There is no pharmacopoeia monograph, no FDA-approved label, and no EMA marketing authorisation for either peptide alone or in combination [1] [2]
Researchers may select from the following formulations: 10 mg 5 mg Sermorelin + 5 mg Ipamorelin 20 mg 10 mg Sermorelin + 10 mg Ipamorelin Take note that each formulation is intended solely for controlled laboratory investigation
Regular follow-up appointments allow your provider to monitor progress, review laboratory findings when appropriate, and determine whether continuing treatment remains beneficial
US$ 26.69
US$ 22.69
US$ 26.57
US$ 28.41
